JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis
Condition: Erosive Esophagitis Interventions: Drug: Experimental drug; Drug: Active comparative drug Sponsor: Onconic Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials